[1]
H. Tang, MSc, J. Zhang, MD, and Y. Song, MD, ScD, “Adverse Effects and Safety of SGLT2 Inhibitor Use among Patients with Type 2 Diabetes: Findings from RCT Evidence”, N A J Med Sci, vol. 10, no. 2, Apr. 2017.